193 related articles for article (PubMed ID: 8842419)
1. Neuroprotective properties of a protein kinase inhibitor against ischaemia-induced neuronal damage in rats and gerbils.
Satoh S; Ikegaki I; Suzuki Y; Asano T; Shibuya M; Hidaka H
Br J Pharmacol; 1996 Aug; 118(7):1592-6. PubMed ID: 8842419
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological profile of hydroxy fasudil as a selective rho kinase inhibitor on ischemic brain damage.
Satoh S; Utsunomiya T; Tsurui K; Kobayashi T; Ikegaki I; Sasaki Y; Asano T
Life Sci; 2001 Aug; 69(12):1441-53. PubMed ID: 11531167
[TBL] [Abstract][Full Text] [Related]
3. Hemorheological abnormalities in experimental cerebral ischemia and effects of protein kinase inhibitor on blood fluidity.
Hitomi A; Satoh S; Ikegaki I; Suzuki Y; Shibuya M; Asano T
Life Sci; 2000 Sep; 67(16):1929-39. PubMed ID: 11072869
[TBL] [Abstract][Full Text] [Related]
4. Wide therapeutic time window for fasudil neuroprotection against ischemia-induced delayed neuronal death in gerbils.
Satoh S; Toshima Y; Ikegaki I; Iwasaki M; Asano T
Brain Res; 2007 Jan; 1128(1):175-80. PubMed ID: 17123488
[TBL] [Abstract][Full Text] [Related]
5. Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brain.
Asano T; Ikegaki I; Satoh S; Mochizuki D; Hidaka H; Suzuki Y; Shibuya M; Sugita K
Br J Pharmacol; 1991 Aug; 103(4):1935-8. PubMed ID: 1912980
[TBL] [Abstract][Full Text] [Related]
6. Fasudil (HA1077), an intracellular calcium antagonist, improves neurological deficits and tissue potassium loss in focal cerebral ischemia in gerbils.
Kondoh Y; Mizusawa S; Murakami M; Nakamichi H; Nagata K
Neurol Res; 1997 Apr; 19(2):211-5. PubMed ID: 9175152
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of SB-221420-A - a neuronal Ca(2+) and Na(+) channel antagonist in experimental models of stroke.
Campbell CA; Barone FC; Benham CD; Hadingham SJ; Harries MH; Harling JD; Hills JM; Lewis VA; Mackay KB; Orlek BS; White RF; Parsons AA; Hunter AJ
Eur J Pharmacol; 2000 Aug; 401(3):419-28. PubMed ID: 10936502
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective potential of fasudil mesylate in brain ischemia-reperfusion injury of rats.
Li Q; Huang XJ; He W; Ding J; Jia JT; Fu G; Wang HX; Guo LJ
Cell Mol Neurobiol; 2009 Mar; 29(2):169-80. PubMed ID: 18785000
[TBL] [Abstract][Full Text] [Related]
9. Fasudil and ozagrel in combination show neuroprotective effects on cerebral infarction after murine middle cerebral artery occlusion.
Koumura A; Hamanaka J; Kawasaki K; Tsuruma K; Shimazawa M; Hozumi I; Inuzuka T; Hara H
J Pharmacol Exp Ther; 2011 Jul; 338(1):337-44. PubMed ID: 21493751
[TBL] [Abstract][Full Text] [Related]
10. Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons.
Yamashita K; Kotani Y; Nakajima Y; Shimazawa M; Yoshimura S; Nakashima S; Iwama T; Hara H
Brain Res; 2007 Jun; 1154():215-24. PubMed ID: 17482584
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of endothelial damage/dysfunction is a possible mechanism for the neuroprotective effects of Rho-kinase inhibitors against ischemic brain damage.
Satoh S; Hitomi A; Ikegaki I; Kawasaki K; Nakazono O; Iwasaki M; Mohri M; Asano T
Brain Res Bull; 2010 Jan; 81(1):191-5. PubMed ID: 19723568
[TBL] [Abstract][Full Text] [Related]
12. Rho-kinase inhibitor, fasudil, prevents neuronal apoptosis via the Akt activation and PTEN inactivation in the ischemic penumbra of rat brain.
Wu J; Li J; Hu H; Liu P; Fang Y; Wu D
Cell Mol Neurobiol; 2012 Oct; 32(7):1187-97. PubMed ID: 22552888
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 synthetase inhibitor failed to ameliorate the arterial narrowing during the chronic phase of cerebral vasospasm.
Toshima Y; Satoh S; Ikegaki I; Asano T; Suzuki Y; Shibuya M
Life Sci; 1997; 61(14):1371-7. PubMed ID: 9335226
[TBL] [Abstract][Full Text] [Related]
14. Wide therapeutic time window for Rho-kinase inhibition therapy in ischemic brain damage in a rat cerebral thrombosis model.
Satoh S; Toshima Y; Hitomi A; Ikegaki I; Seto M; Asano T
Brain Res; 2008 Feb; 1193():102-8. PubMed ID: 18187127
[TBL] [Abstract][Full Text] [Related]
15. Comparative protective effects of nicardipine, flunarizine, lidoflazine and nimodipine against ischaemic injury in the hippocampus of the Mongolian gerbil.
Alps BJ; Calder C; Hass WK; Wilson AD
Br J Pharmacol; 1988 Apr; 93(4):877-83. PubMed ID: 3390655
[TBL] [Abstract][Full Text] [Related]
16. Effect of ozagrel on locomotor and motor coordination after transient cerebral ischemia in experimental animal models.
Ichikawa K; Tazawa S; Hamano S; Kojima M; Hiraku S
Pharmacology; 1999 Nov; 59(5):257-65. PubMed ID: 10529658
[TBL] [Abstract][Full Text] [Related]
17. A new model of cerebral microthrombosis in rats and the neuroprotective effect of a Rho-kinase inhibitor.
Toshima Y; Satoh S; Ikegaki I; Asano T
Stroke; 2000 Sep; 31(9):2245-50. PubMed ID: 10978059
[TBL] [Abstract][Full Text] [Related]
18. Involvement of RhoA and possible neuroprotective effect of fasudil, a Rho kinase inhibitor, in NMDA-induced neurotoxicity in the rat retina.
Kitaoka Y; Kitaoka Y; Kumai T; Lam TT; Kuribayashi K; Isenoumi K; Munemasa Y; Motoki M; Kobayashi S; Ueno S
Brain Res; 2004 Aug; 1018(1):111-8. PubMed ID: 15262212
[TBL] [Abstract][Full Text] [Related]
19. Reduction by lifarizine of the neuronal damage induced by cerebral ischaemia in rodents.
Alps BJ; Calder C; Wilson AD; McBean DE; Armstrong JM
Br J Pharmacol; 1995 Aug; 115(8):1439-46. PubMed ID: 8564203
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions.
Gibson CL; Srivastava K; Sprigg N; Bath PM; Bayraktutan U
J Neurochem; 2014 Jun; 129(5):816-26. PubMed ID: 24528233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
